Participants started at 2mg and increased to 4mg, then 6mg, then 9mg, and finally 12mg for the highest dose group
(As a bonus, its also inexpensive.) While LDN is not studied specifically for menopause, its anti-inflammatory and immune-modulating properties may address some inflammation-driven symptoms that become more noticeable during this life stage , says Ava Mainieri, PhD, Director of Clinical Outcomes and Programming at Midi Health
The prevailing understanding is that BPC 157s systemic action is sufficient, making SubQ injections effective, safer, and easier to administer for virtually all applications
For external cosmetic use only
JAMA 310:2435 Lamberti P et al (2005) Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinsons disease patients
Peptide therapy is designed to support specific biological functions by using compounds that mimic the bodys natural signaling molecules